Psilocybin study of brain activity and changing thoughts
Treatments studied
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old and able to give written consent
- Be healthy and psychologically stable after medical and mental health screening
- Fluent in English and have at least a high-school education (or equivalent)
- Be willing to follow substance and medication timing rules (no alcohol/nicotine/other drugs before sessions; no caffeine changes; avoid certain medications ahead of time)
- Have used a psychedelic at least five times in your life
- Be able to have MRI scans (no MRI limits like certain implants, and able to tolerate the scanner)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking pimavanserin before psilocybin changes the drug's effects in healthy volunteers who have never used psychedelics. It aims to understand how to make psychedelic therapy safer and more predictable.
This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
This study tests how music affects your experience with psilocybin, a psychedelic substance. It may help researchers understand how to create the best setting for psilocybin therapy.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.